Compare Stocks: TEM, LH, DGX, and GH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$231.07 +0.1%	$237.59	$171.18 ▼ $248.84	$25.50B	0.54	977,979 shs	775,436 shs
GH Guardant Health	$167.47 +1.2%	$167.74	$61.00 ▼ $191.05	$22.47B	1.58	2.23 million shs	1.52 million shs
LH Labcorp	$311.99 -0.7%	$320.16	$244.52 ▼ $341.80	$25.30B	0.87	694,600 shs	607,853 shs
TEM Tempus AI	$70.93 +2.4%	$65.48	$40.77 ▼ $101.56	$12.80B	3.54	6.25 million shs	6.24 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+1.68%	+0.02%	-2.13%	+11.15%	+27.59%
GH Guardant Health	-1.65%	-5.26%	+2.85%	+3.44%	+153.46%
LH Labcorp	+0.88%	+3.32%	-3.20%	+13.63%	+13.36%
TEM Tempus AI	-1.52%	-9.44%	+7.76%	+18.98%	-32.90%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$231.07 +0.1%	$237.59	$171.18 ▼ $248.84	$25.50B	0.54	977,979 shs	775,436 shs
GH Guardant Health	$167.47 +1.2%	$167.74	$61.00 ▼ $191.05	$22.47B	1.58	2.23 million shs	1.52 million shs
LH Labcorp	$311.99 -0.7%	$320.16	$244.52 ▼ $341.80	$25.30B	0.87	694,600 shs	607,853 shs
TEM Tempus AI	$70.93 +2.4%	$65.48	$40.77 ▼ $101.56	$12.80B	3.54	6.25 million shs	6.24 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+1.68%	+0.02%	-2.13%	+11.15%	+27.59%
GH Guardant Health	-1.65%	-5.26%	+2.85%	+3.44%	+153.46%
LH Labcorp	+0.88%	+3.32%	-3.20%	+13.63%	+13.36%
TEM Tempus AI	-1.52%	-9.44%	+7.76%	+18.98%	-32.90%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.58	Moderate Buy	$237.85	2.93% Upside
GH Guardant Health	2.96	Moderate Buy	$189.38	13.08% Upside
LH Labcorp	2.75	Moderate Buy	$337.73	8.25% Upside
TEM Tempus AI	2.41	Hold	$71.05	0.17% Upside

Current Analyst Ratings Breakdown

Latest TEM, LH, DGX, and GH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/7/2026	DGX Quest Diagnostics	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$250.00 ➝ $260.00
10/7/2026	GH Guardant Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$200.00 ➝ $220.00
10/6/2026	DGX Quest Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (A-) ➝ Buy (A)
10/6/2026	LH Labcorp	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (B) ➝ Buy (B+)
10/1/2026	TEM Tempus AI	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$65.00 ➝ $92.00
10/1/2026	GH Guardant Health	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$190.00 ➝ $200.00
9/28/2026	TEM Tempus AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/21/2026	TEM Tempus AI	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$75.00
9/21/2026	DGX Quest Diagnostics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$250.00 ➝ $260.00
9/21/2026	LH Labcorp	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$350.00 ➝ $365.00
9/21/2026	TEM Tempus AI	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$75.00

(Data available from 10/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$11.56B	2.21	$15.45 per share	14.96	$64.78 per share	3.57
GH Guardant Health	$1.18B	19.00	N/A	N/A	($0.79) per share	-211.99
LH Labcorp	$13.95B	1.81	$24.84 per share	12.56	$103.98 per share	3.00
TEM Tempus AI	$1.27B	10.06	N/A	N/A	$2.76 per share	25.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$992M	$9.42	24.53	19.30	2.05	9.18%	16.01%	7.27%	10/22/2026 (Estimated)
GH Guardant Health	-$416.28M	-$3.49	N/A	N/A	N/A	-38.33%	N/A	-25.40%	10/28/2026 (Estimated)
LH Labcorp	$876.50M	$12.09	25.81	15.85	1.78	6.99%	16.74%	7.81%	10/28/2026 (Estimated)
TEM Tempus AI	-$245.03M	-$1.44	N/A	N/A	N/A	-17.77%	-50.28%	-10.33%	11/3/2026 (Estimated)

Latest TEM, LH, DGX, and GH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/3/2026	Q3 2026	TEM Tempus AI	-$0.07	N/A	N/A	N/A	$409.42 million	N/A
10/28/2026	Q3 2026	GH Guardant Health	-$0.7526	N/A	N/A	N/A	$350.60 million	N/A
10/28/2026	Q3 2026	LH Labcorp	$4.65	N/A	N/A	N/A	$3.76 billion	N/A
10/22/2026	Q3 2026	DGX Quest Diagnostics	$2.87	N/A	N/A	N/A	$3.05 billion	N/A
7/30/2026	Q2 2026	GH Guardant Health	-$0.7618	-$0.42	+$0.3418	-$0.90	$314.23 million	$334.98 million
7/30/2026	Q2 2026	LH Labcorp	$4.78	$4.99	+$0.21	$3.64	$3.71 billion	$3.73 billion
7/30/2026	Q2 2026	TEM Tempus AI	-$0.1428	-$0.04	+$0.1028	$0.03	$379.69 million	$382.49 million
7/23/2026	Q2 2026	DGX Quest Diagnostics	$2.82	$3.12	+$0.30	$2.84	$2.97 billion	$3.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.44	1.49%	+7.34%	36.52%	14 Years
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	0.92%	N/A	23.82%	N/A
TEM Tempus AI	N/A	N/A	N/A	N/A	N/A

Latest TEM, LH, DGX, and GH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	DGX Quest Diagnostics	quarterly	$0.86	1.51%	10/6/2026	10/6/2026	10/21/2026
7/9/2026	LH Labcorp	quarterly	$0.72	0.86%	8/28/2026	8/28/2026	9/11/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.72	1.59	1.46
GH Guardant Health	N/A	4.03	3.71
LH Labcorp	0.69	1.80	1.53
TEM Tempus AI	3.06	3.30	3.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
GH Guardant Health	92.60%
LH Labcorp	95.94%
TEM Tempus AI	24.22%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	0.88%
GH Guardant Health	5.60%
LH Labcorp	0.84%
TEM Tempus AI	24.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	57,000	110.37 million	109.40 million	Optionable
GH Guardant Health	2,506	134.20 million	126.68 million	Not Optionable
LH Labcorp	71,000	81.10 million	80.42 million	Optionable
TEM Tempus AI	3,800	180.43 million	136.66 million	N/A

TEM, LH, DGX, and GH Headlines

Recent News About These Companies

Could You Have Seen The Run In Tempus AI Stock Coming?

1 hour ago | finance.yahoo.com

Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?

October 9 at 10:56 AM | zacks.com

Tempus CEO on How AI Can Save Healthcare

October 8 at 6:55 PM | wsj.com

Promising Artificial Intelligence Stocks To Follow Now - October 7th

October 7 at 12:01 PM | marketbeat.com

Tempus AI Drops 12.7% in One Session, Erasing Billions

October 6 at 12:57 AM | 247wallst.com

Tempus AI Drops 15.3% After-Hours, Shedding About $2 Billion

October 6 at 12:57 AM | 247wallst.com

Top Artificial Intelligence Stocks To Add to Your Watchlist - October 6th

October 6 at 12:02 PM | americanbankingnews.com

Tempus AI (TEM) Shares Just Moved, So What Is Going On?

October 6 at 9:54 AM | finance.yahoo.com

Here's How Tempus AI is Capitalizing on AI-ECG Market Growth

October 5, 2026 | zacks.com

Artificial Intelligence Stocks To Watch Now - October 5th

October 5, 2026 | marketbeat.com

Best Artificial Intelligence Stocks Worth Watching - October 3rd

October 5, 2026 | americanbankingnews.com

Promising Artificial Intelligence Stocks To Add to Your Watchlist - October 4th

October 4, 2026 | marketbeat.com

Consensus price target for Tempus AI increased by 17.40% to MX$1,423.09

October 2, 2026 | msn.com

Tempus AI (NASDAQ:TEM) Shares Down 6.1% - Here's Why

October 1, 2026 | marketbeat.com

Artificial Intelligence Stocks To Follow Today - October 1st

October 1, 2026 | marketbeat.com

10 Stocks With Massive Short Squeeze Potential

October 1, 2026 | schaeffersresearch.com

Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026

October 1, 2026 | businesswire.com

The Top HealthTech Questions Landing on Our Desks

September 30, 2026 | etftrends.comE

Top Artificial Intelligence Stocks To Consider - September 28th

September 30, 2026 | americanbankingnews.com

Best Artificial Intelligence Stocks To Consider - September 29th

September 29, 2026 | marketbeat.com

Best Artificial Intelligence Stocks Worth Watching - September 27th

September 29, 2026 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TEM, LH, DGX, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

$231.07 +0.26 (+0.11%)

Closing price 03:59 PM Eastern

Extended Trading

$230.90 -0.18 (-0.08%)

As of 04:20 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Guardant Health NASDAQ:GH

$167.47 +1.91 (+1.15%)

Closing price 04:00 PM Eastern

Extended Trading

$167.40 -0.07 (-0.04%)

As of 04:15 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Labcorp NYSE:LH

$311.99 -2.21 (-0.70%)

Closing price 03:59 PM Eastern

Extended Trading

$312.23 +0.24 (+0.08%)

As of 04:20 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Tempus AI NASDAQ:TEM

$70.93 +1.65 (+2.38%)

Closing price 04:00 PM Eastern

Extended Trading

$71.19 +0.26 (+0.37%)

As of 04:43 PM Eastern

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TEM, LH, DGX, and GH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TEM, LH, DGX, and GH Earnings

Compare Dividends

Latest TEM, LH, DGX, and GH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TEM, LH, DGX, and GH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TEM, LH, DGX, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

Guardant Health NASDAQ:GH

Labcorp NYSE:LH

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools